Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infection-Reference-Cited by-同舟云学术

Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infection

Published:2019-02-26 Issue:4 Volume:28 Page:323-335
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Tran Mai-Chi N.¹²,Kullar Ravina³,Goldstein Ellie J. C.⁴⁵

Affiliation:

1. Department of Pharmacy, Providence St. John’s Health Center, Santa Monica, CA, USA

2. Department of Pharmacy, Clinica Juan Pablo Medical Group, Los Angeles, CA, USA

3. Doctor Evidence, LLC, Santa Monica, CA, USA

4. R M Alden Research Laboratory, Santa Monica, CA, USA

5. David Geffen School of Medicine, Los Angeles, CA, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1581763

Reference103 articles.

1. Health Care–Associated Infections

2. Centers for Medicare and Medicaid Services: Medicare Learning Network. Hospital Value-Based Purchasing; 2017. Available from: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/Hospital_VBPurchasing_Fact_Sheet_ICN907664.pdf [Cited 2018 Dec 1].

3. CMS Changes in Reimbursement for HAIs

4. Burden of Gastrointestinal Disease in the United States: 2012 Update

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The small acid-soluble proteins of Clostridioides difficile are important for UV resistance and serve as a check point for sporulation;PLOS Pathogens;2021-09-08

2. The small acid-soluble proteins of Clostridioides difficile are important for UV resistance and serve as a check point for sporulation;2021-03-29

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)

;Journal of Experimental Pharmacology;2020-10

4. A contemporary review of Clostridioides difficile infections in patients with haematologic diseases;Journal of Internal Medicine;2020-09-25

5. Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections;Bioorganic & Medicinal Chemistry;2019-08